Published in Nat Rev Immunol on June 01, 2010
Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN) | NCT02673840
Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol (2011) 2.92
Innate immunity in the central nervous system. J Clin Invest (2012) 2.77
Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood (2013) 1.94
Mast cells and inflammation. Biochim Biophys Acta (2010) 1.91
Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity (2013) 1.80
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta (2013) 1.60
Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol (2012) 1.54
Protective and pathological roles of mast cells and basophils. Nat Rev Immunol (2013) 1.54
Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP. Immunity (2013) 1.53
Regulation of mast cell responses in health and disease. Crit Rev Immunol (2011) 1.50
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res (2014) 1.37
Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chem Rev (2011) 1.29
Perioperative organ injury. Anesthesiology (2013) 1.27
Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis (2012) 1.25
The role of mast cells in the defence against pathogens. PLoS Pathog (2012) 1.21
New models for analyzing mast cell functions in vivo. Trends Immunol (2012) 1.19
Innate immunity and its regulation by mast cells. J Immunol (2013) 1.19
Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 1.19
Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest (2011) 1.16
Polyphosphate is a novel pro-inflammatory regulator of mast cells and is located in acidocalcisomes. J Biol Chem (2012) 1.14
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 1.12
TLR signaling in mast cells: common and unique features. Front Immunol (2012) 1.12
Innate immune cells in liver inflammation. Mediators Inflamm (2012) 1.11
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev (2012) 1.11
Early weaning stress in pigs impairs innate mucosal immune responses to enterotoxigenic E. coli challenge and exacerbates intestinal injury and clinical disease. PLoS One (2013) 1.10
Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 1.10
Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2012) 1.09
Mast cell function: a new vision of an old cell. J Histochem Cytochem (2014) 1.08
Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. J Immunol (2011) 1.06
Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model. PLoS One (2013) 1.06
Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. J Immunol (2012) 1.03
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis. Small (2012) 1.02
CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-α. PLoS One (2012) 1.01
The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect (2011) 1.01
Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J Exp Med (2012) 1.00
Touch of chemokines. Front Immunol (2012) 1.00
Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci (2015) 0.99
Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2013) 0.99
Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest (2016) 0.99
The SNARE Machinery in Mast Cell Secretion. Front Immunol (2012) 0.98
Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. Proc Natl Acad Sci U S A (2011) 0.98
Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist's Perspective. Int Neurourol J (2015) 0.97
Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice. Arthritis Rheumatol (2014) 0.97
Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J Biol Chem (2013) 0.97
Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Lab Invest (2012) 0.96
FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment. PLoS One (2012) 0.95
Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells. Front Immunol (2014) 0.94
Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J Immunol (2013) 0.94
Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice. Haematologica (2015) 0.93
Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog (2014) 0.93
The role of IL-17-secreting mast cells in inflammatory joint disease. Nat Rev Rheumatol (2012) 0.92
Mast Cells Respond to Cell Injury through the Recognition of IL-33. Front Immunol (2012) 0.91
Autoinflammation: translating mechanism to therapy. J Leukoc Biol (2011) 0.91
IL-33 activates tumor stroma to promote intestinal polyposis. Proc Natl Acad Sci U S A (2015) 0.90
Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing. Nat Immunol (2016) 0.90
Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. J Clin Invest (2014) 0.89
Mast cells as cellular sensors in inflammation and immunity. Front Immunol (2011) 0.89
Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils. Invest Ophthalmol Vis Sci (2015) 0.88
Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms. Cell Mol Immunol (2014) 0.88
IgE and mast cells in host defense against parasites and venoms. Semin Immunopathol (2016) 0.88
Immune cell location and function during post-natal mammary gland development. J Mammary Gland Biol Neoplasia (2010) 0.88
Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One (2012) 0.88
A20-deficient mast cells exacerbate inflammatory responses in vivo. PLoS Biol (2014) 0.88
The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis. Am J Pathol (2016) 0.88
Mast cells and company. Front Immunol (2012) 0.87
Regulation of Lipid Signaling by Diacylglycerol Kinases during T Cell Development and Function. Front Immunol (2013) 0.87
Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62. J Parasitol Res (2013) 0.87
Expression profiling of constitutive mast cells reveals a unique identity within the immune system. Nat Immunol (2016) 0.87
Neutrophil migration in infection and wound repair: going forward in reverse. Nat Rev Immunol (2016) 0.87
The nature of immune responses to urinary tract infections. Nat Rev Immunol (2015) 0.86
Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol (2015) 0.86
Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol (2013) 0.86
Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv Immunol (2015) 0.85
Mast cells and influenza a virus: association with allergic responses and beyond. Front Immunol (2015) 0.85
Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo. Immunology (2014) 0.84
A novel function for SNAP29 (synaptosomal-associated protein of 29 kDa) in mast cell phagocytosis. PLoS One (2012) 0.84
Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors. Elife (2015) 0.84
Role and relevance of mast cells in fungal infections. Front Immunol (2012) 0.84
Anti-allergic role of cholinergic neuronal pathway via α7 nicotinic ACh receptors on mucosal mast cells in a murine food allergy model. PLoS One (2014) 0.84
Tetraspanins in mast cells. Front Immunol (2012) 0.84
The success of microneedle-mediated vaccine delivery into skin. Hum Vaccin Immunother (2016) 0.83
Influence of mast cells on dengue protective immunity and immune pathology. PLoS Pathog (2013) 0.83
Fibromyalgia Syndrome in Need of Effective Treatments. J Pharmacol Exp Ther (2015) 0.83
Mast cells play a critical role in the systemic inflammatory response and end-organ injury resulting from trauma. J Am Coll Surg (2011) 0.83
Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor. Mucosal Immunol (2013) 0.83
Porcine intestinal mast cells. Evaluation of different fixatives for histochemical staining techniques considering tissue shrinkage. Eur J Histochem (2013) 0.83
Mast Cells as Regulators of T Cell Responses. Front Immunol (2015) 0.83
Identification of microRNAs regulating the developmental pathways of bone marrow derived mast cells. PLoS One (2014) 0.82
Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice. PLoS One (2011) 0.82
Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm (2011) 0.82
New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development. Exp Mol Med (2014) 0.81
Human Mucosal Mast Cells Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells. J Virol (2015) 0.81
Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin. J Allergy Clin Immunol (2011) 0.81
Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties. Oncotarget (2015) 0.81
Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells. Semin Immunopathol (2016) 0.80
Regulatory roles of mast cells in immune responses. Semin Immunopathol (2016) 0.80
Evidence that meningeal mast cells can worsen stroke pathology in mice. Am J Pathol (2014) 0.80
Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (2001) 11.23
Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol (2007) 7.23
Mast cells. Physiol Rev (1997) 6.51
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (1996) 5.48
Mast cells in the development of adaptive immune responses. Nat Immunol (2005) 4.96
Critical protective role of mast cells in a model of acute septic peritonitis. Nature (1996) 4.71
Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature (1990) 4.21
New developments in mast cell biology. Nat Immunol (2008) 3.72
Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol (2002) 2.96
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature (1998) 2.82
Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol (2007) 2.75
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol (2003) 2.68
Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med (2008) 2.27
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest (2002) 2.22
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci U S A (1986) 2.18
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol (2004) 2.02
Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med (2000) 2.00
IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med (2007) 2.00
Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J Exp Med (2000) 1.98
Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature (2004) 1.91
Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol (1991) 1.82
Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol (2003) 1.79
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev (2007) 1.78
The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem (2007) 1.69
Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature (1985) 1.63
FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood (2005) 1.54
Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J Immunol (2008) 1.53
The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A (1999) 1.52
Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol (2008) 1.48
Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol (2005) 1.48
Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol (1997) 1.44
Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol (2009) 1.44
IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol (2008) 1.43
Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol (2009) 1.43
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood (2005) 1.39
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol (1996) 1.37
Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol (2003) 1.35
Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J Immunol (1990) 1.32
Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol (2005) 1.32
Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules. J Cell Biol (1982) 1.31
Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J Immunol (1998) 1.30
A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. Chem Pharm Bull (Tokyo) (1979) 1.27
Mast cell-T cell interactions. J Allergy Clin Immunol (1999) 1.26
Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology (1998) 1.24
Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med (2008) 1.23
Mast cells in infection and immunity. Infect Immun (1997) 1.23
Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc Natl Acad Sci U S A (2008) 1.21
Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J (2006) 1.21
Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. J Immunol (2009) 1.20
Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol (2000) 1.18
IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol (2004) 1.18
Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood (2007) 1.17
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe (2009) 1.17
Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med (2005) 1.16
Defective protective capacity of W/Wv mice against Strongyloides ratti infection and its reconstitution with bone marrow cells. Parasite Immunol (1985) 1.15
HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol (2000) 1.11
Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol Lett (2004) 1.10
Protective roles of mast cells and mast cell-derived TNF in murine malaria. J Immunol (2006) 1.10
Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity (2009) 1.10
Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J Biol Chem (2007) 1.10
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol (2007) 1.10
Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem (1992) 1.09
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. Vaccine (2009) 1.09
Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol (2006) 1.07
Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol (2006) 1.07
Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect Immun (2005) 1.05
Interactions of mast cells with the nervous system--recent advances. Neurochem Res (1992) 1.04
Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol (2003) 1.04
Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood (2008) 1.03
Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur J Immunol (2007) 1.03
Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood (1998) 1.02
Nerves and Intestinal Mast Cells Modulate Responses to Enterotoxins. News Physiol Sci (1998) 1.00
Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun (2008) 1.00
Limit dilution analysis of mast cell precursor frequency in the gut epithelium of normal and Trichinella spiralis infected mice. Parasite Immunol (1986) 1.00
Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol (2001) 0.99
Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol (2000) 0.99
Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation (1995) 0.98
Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood (2007) 0.97
IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol (2001) 0.95
Histamine release from rat mast cells induced by Sendai virus. Nature (1977) 0.93
Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun (2000) 0.93
Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am J Pathol (1990) 0.92
Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. Cell Signal (2003) 0.91
Rapidly changing perspectives about mast cells at mucosal surfaces. Immunol Rev (2005) 0.90
Histamine improves antigen uptake and cross-presentation by dendritic cells. J Immunol (2007) 0.89
Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol (1989) 0.88
Infection with Nippostrongylus brasiliensis induces invasion of mast cell precursors from peripheral blood to small intestine. Blood (1995) 0.88
Recycling of mast cells following degranulation in vitro: an ultrastructural study. Tissue Cell (1982) 0.88
A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin. J Exp Med (1995) 0.88
Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases. J Immunol (2009) 0.86
Mast cell heterogeneity: two-dimensional gel electrophoretic analyses of rat peritoneal and intestinal mucosal mast cells. Eur J Immunol (1990) 0.85
Virus-induced increases in bronchiolar mast cells in Brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab Invest (1995) 0.83
Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology (2009) 0.81
Antibody-mediated enhancement of infection by dengue virus of the P815 murine mastocytoma cell line. Biken J (1986) 0.80
Stem cell factor dependent hyperplasia of mucosal-type mast cells but not eosinophils in Schistosoma mansoni-infected rats. Parasite Immunol (1995) 0.79
Mast cells in innate and adaptive immunity to infection. Eur J Immunol (2010) 0.78
Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity (2013) 1.80
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 1.19
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe (2009) 1.17
Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol (2011) 0.85